By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BeiGene Co.,Ltd 

No.30 Science Park Road
Zhong-Guan-Cun Life Science Park
Changping District  Beijing    China
Phone: n/a Fax: n/a



Company News
China's BeiGene (BGNE) Starts Combination Trial For Two Novel Cancer Drugs 7/7/2016 9:09:18 AM
BeiGene Presents Positive Interim Data From Trial Of RAF-Inhibitor 4/19/2016 12:15:39 PM
BeiGene Announces Presentations On BGB-283 And Other Pipeline Agents At The 2016 AACR Annual Meeting 3/17/2016 8:07:15 AM
BeiGene Receives Approval To Initiate Clinical Trials In China With BGB-3111 3/7/2016 9:57:47 AM
BeiGene To Present At Cowen and Company 36th Annual Health Care Conference 3/1/2016 8:27:03 AM
BeiGene Announces Closing Of Its Initial Public Offering 2/9/2016 8:04:06 AM
Week In Review: BeiGene Completes $158 Million IPO In The US 2/8/2016 9:07:47 AM
BeiGene Announces Pricing Of Its Initial Public Offering 2/3/2016 6:19:24 AM
Week In Review: BeiGene Schedules $128 Million IPO For February 1/25/2016 9:39:45 AM
BeiGene Plans $127 Million U.S. IPO In February 1/21/2016 1:34:42 PM